Biotech Medics Ne Stock Analysis
| BMCS Stock | USD 0.01 0.00 0.00% |
Biotech Medics Ne is fairly valued with Real Value of 0.009765 and Hype Value of 0.01. The main objective of Biotech Medics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Biotech Medics Ne is worth, separate from its market price. There are two main types of Biotech Medics' stock analysis: fundamental analysis and technical analysis.
The Biotech Medics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Biotech |
Biotech Pink Sheet Analysis Notes
The company recorded a loss per share of 0.0. Biotech Medics Ne had not issued any dividends in recent years. The entity had 1:20 split on the 16th of November 2007. BioTech Medics, Inc. operates as a medical-based holding company. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida. Biotech Medics is traded on OTC Exchange in the United States.The quote for Biotech Medics Ne is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Biotech Medics Ne please contact the company at 972-274-5533 or go to https://biotecmedics.com.Biotech Medics Ne Investment Alerts
| Biotech Medics Ne generated a negative expected return over the last 90 days | |
| Biotech Medics Ne has high historical volatility and very poor performance | |
| Biotech Medics Ne has some characteristics of a very speculative penny stock | |
| The company has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Biotech Medics until it has trouble settling it off, either with new capital or with free cash flow. So, Biotech Medics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotech Medics Ne sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotech to invest in growth at high rates of return. When we think about Biotech Medics' use of debt, we should always consider it together with cash and equity. | |
| Biotech Medics Ne reported the previous year's revenue of 469.8 K. Net Loss for the year was (603.72 K) with profit before overhead, payroll, taxes, and interest of 408.14 K. |
Biotech Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 870.4 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotech Medics's market, we take the total number of its shares issued and multiply it by Biotech Medics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Biotech Profitablity
The company has Profit Margin (PM) of (1.29) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.24) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.24.Technical Drivers
As of the 23rd of March, Biotech Medics shows the Mean Deviation of 2.92, risk adjusted performance of (0.06), and Standard Deviation of 5.74. Biotech Medics Ne technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Biotech Medics Ne variance and potential upside to decide if Biotech Medics Ne is priced correctly, providing market reflects its regular price of 0.01 per share. As Biotech Medics Ne appears to be a penny stock we also recommend to validate its jensen alpha numbers.Biotech Medics Ne Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biotech Medics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biotech Medics Ne. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Biotech Medics Outstanding Bonds
Biotech Medics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biotech Medics Ne uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biotech bonds can be classified according to their maturity, which is the date when Biotech Medics Ne has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
| BIOGEN INC 405 Corp BondUS09062XAF06 | View | |
| BIOGEN INC Corp BondUS09062XAG88 | View | |
| BIOGEN INC Corp BondUS09062XAH61 | View |
Biotech Medics Predictive Daily Indicators
Biotech Medics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biotech Medics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Biotech Medics Forecast Models
Biotech Medics' time-series forecasting models are one of many Biotech Medics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biotech Medics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Biotech Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Biotech Medics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotech shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Biotech Medics. By using and applying Biotech Pink Sheet analysis, traders can create a robust methodology for identifying Biotech entry and exit points for their positions.
BioTech Medics, Inc. operates as a medical-based holding company. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida. Biotech Medics is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Biotech Medics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Additional Tools for Biotech Pink Sheet Analysis
When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.